~~<i id='97A8DD5A04'><strike id='97A8DD5A04'><tt id='97A8DD5A04'><pre id='97A8DD5A04'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

Wikipedia

hotspot

author：comprehensive 2025-09-03 05:38:38 - browse：4

MADRID — Merck is paying billions of dollars to partner with Daiichi Sankyo on a series of cancer drugs, underscoring the excitement around targeted chemotherapy treatments.

The deal includes a $4 billion upfront payment and an additional $1.5 billion over the next two years. Up to $16.5 billion more is on the table depending on the success of the drugs in development.

The announcement on Thursday night in the United States came on the eve of one the cancer field’s biggest annual conferences, the European Society for Medical Oncology Congress, being held this year in Madrid.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： Readout Newsletter: CG Oncology IPO, Eli Lilly, Tesla, Merck

hotspot

knowledge

explore

Wikipedia

focus

SummaHealthGeneralCatalysts’sgrandvisionforaventurecapital-ownedhospitalsystemseamlesslyblendingAIan

WSS

10 reasons why health care startups fail

The a glaring gap in research on serious mental illness and primary care

Biotech startup Celsius cuts 75% of staff ahead of first trial start

Readout Newsletter: The latest on Novavax, Merck, Bluebird

FTC sues over Novant Health acquisition of two N.C. hospitals

Listen: Biotech layoffs, eye drug drama, & gene therapy milestones

Wikipedia

hotspot

hotspot

Sports medicine is finally prioritizing gender equality

Zyn nicotine pouches become unlikely player in latest culture war

After affirmative action ruling, medical educators look to 'holistic review'

Venture capital firm's plans to take over Akron hospital face hurdles

United colonoscopy coverage change 'may cost lives,' doctors say

Medicare Advantage insurers face 0.2% cut to 2025 payments

Hollywood unions extend contract negotiations for actors

Why you shouldn’t ask, “What country has the best health care?”

Wildfire smoke exposes gaps in outdoor worker protections

Merck CEO won’t testify in Senate, citing no expertise in drug prices

knowledge

How to ethically and practically extend health care to all

The cancer stories no one wants to hear

White House pharmacy plagued with problems, investigation finds

Medicare drug price negotiation legal challenge met with skepticism

Medicare slashes safety net hospital payments by nearly $1 billion

Investment in vaccine development is lagging, report finds

explore

Wikipedia

focus

focus